首页> 外文期刊>The American Journal of Human Genetics >Abundant pleiotropy in human complex diseases and traits.
【24h】

Abundant pleiotropy in human complex diseases and traits.

机译:人类复杂疾病和特征中的多效性。

获取原文
获取原文并翻译 | 示例
       

摘要

We present a systematic review of pleiotropy among SNPs and genes reported to show genome-wide association with common complex diseases and traits. We find abundant evidence of pleiotropy; 233 (16.9%) genes and 77 (4.6%) SNPs show pleiotropic effects. SNP pleiotropic status was associated with gene location (p = 0.024; pleiotropic SNPs more often exonic [14.5% versus 4.9% for nonpleiotropic, trait-associated SNPs] and less often intergenic [15.8% versus 23.6%]), "predicted transcript consequence" (p = 0.001; pleiotropic SNPs more often predicted to be structurally deleterious [5% versus 0.4%] but not more often in regulatory sequences), and certain disease classes. We develop a method to calculate the likelihood that pleiotropic links between traits occurred more often than expected and demonstrate that this approach can identify etiological links that are already known (such as between fetal hemoglobin and malaria risk) and those that are not yet established (e.g., between plasma campesterol levels and gallstones risk; and between immunoglobulin A and juvenile idiopathic arthritis). Examples of pleiotropy will accumulate over time, but it is already clear that pleiotropy is a common property of genes and SNPs associated with disease traits, and this will have implications for identification of molecular targets for drug development, future genetic risk-profiling, and classification of diseases.
机译:我们目前对SNPs和基因的多效性进行系统的审查,报告显示基因组范围内与常见的复杂疾病和性状相关。我们发现了很多有关多效性的证据。 233(16.9%)个基因和77(4.6%)个SNP具有多效性效应。 SNP的多效性状态与基因位置相关(p = 0.024;多效性SNPs多为外显子[14.5%,非特质性状相关SNPs为4.9%],而基因间少见[15.8%vs 23.6%]),“预测的转录结果” (p = 0.001;多效性SNP更常被预测为结构有害的(5%对0.4%),但在调节序列中却不多见)和某些疾病类别。我们开发了一种方法来计算性状之间的多效性联系发生的可能性比预期的多,并证明该方法可以识别已知的病因学联系(例如胎儿血红蛋白和疟疾风险之间)和尚未建立的病因学联系(例如,血浆胆固醇水平和胆结石风险之间,免疫球蛋白A与青少年特发性关节炎之间)。多效性的例子会随着时间的推移而积累,但已经清楚的是,多效性是与疾病性状相关的基因和SNP的共同特性,这将对鉴定药物开发,未来的遗传风险概况分析和分类的分子靶标产生影响。疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号